Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection

This publication has 12 references indexed in Scilit:

• Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1990
• Antiviral Chemotherapy for Infection with Human Immunodeficiency Virus
  Clinical Infectious Diseases, 1989
• Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
  New England Journal of Medicine, 1989
• The Antiviral Effect of Zidovudine and Ribavirin in Clinical Trials and the Use of p24 Antigen Levels as a Virologic Marker
  The Journal of Infectious Diseases, 1989
• In Vitro Evaluation of Mismatched Double-Stranded RNA (Ampligen) for Combination Therapy in the Treatment of Acquired Immunodeficiency Syndrome
  AIDS Research and Human Retroviruses, 1989
• Characteristics of tuberculosis in HIV-infected patients
  AIDS, 1988
• Ribavirin Treatment of the Acquired Immunodeficiency Syndrome (AIDS) and the Acquired-Immunodeficiency-Syndrome-Related Complex (ARC)
  Annals of Internal Medicine, 1987
• Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome
  Clinical Pharmacology & Therapeutics, 1987
• Biochemistry and clinical applications of ribavirin
  Antimicrobial Agents and Chemotherapy, 1986
• RIBAVIRIN SUPPRESSES REPLICATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS IN CULTURES OF HUMAN ADULT T LYMPHOCYTES
  The Lancet, 1984